Both LED Red Light And Blue Light Effective In Treatment Of Mild-To-Moderate Acne: Study
- byDoctor News Daily Team
- 13 July, 2025
- 0 Comments
- 0 Mins
LED RL and BL both appear effective in the treatment of mild-to-moderate acne, according to a recent study published in Photodermatology, Photoimmunology & Photomedicine.
Red and blue light therapies are safe and effective treatments for mild-to-moderate acne vulgaris. However, very few previous studies have directly compared the characteristics of these two methods.
A group of researchers conducted a study to compare the efficacy and side effects of red light (RL) and blue light (BL) for acne vulgaris and to assess these two therapies in different types of lesions.
A total of 28 subjects with mild-to-moderate acne vulgaris were randomized into the red light (RL) group or the blue light (BL) group. Subjects in each group received different light treatments, and they were followed up regularly until 2 weeks after the last treatment. The improvement rates of different types of acne lesions were compared between the 2 groups, as well as the incidence of adverse reactions.
The Results of the study are:
At the 2-week follow-up, the average improvement rate of total acne lesions was 36.2% in the red light (RL) group and 30.7% in the blue light (BL) group (p > .05). The average improvement rate of inflammatory and non-inflammatory lesions was 51.5% and 17.3% in the red light (RL) group, compared with 26.4% and 10.0% in the blue light (BL) group (all p > .05). Treatment-related adverse reactions were observed distinctly in the BL group.
Thus, the researchers concluded that red light (RL) and blue light (BL) therapies have similar efficacy in mild-to-moderate acne vulgaris, especially for inflammatory lesions. Red light (RL) had advantages with fewer adverse reactions compared with blue light (BL).
Reference:
Comparison of red light and blue light therapies for mild-to-moderate acne vulgaris: A randomized controlled clinical study by Jiahua Li et al. published in the Photodermatology, Photoimmunology & Photomedicine.
https://pubmed.ncbi.nlm.nih.gov/34981580/
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
Eli Lilly plans to build new USD 3 billion facilit...
- 04 November, 2025
Rajkot Maternity Hospital CCTV Leak: How a simple...
- 04 November, 2025
Gland Pharma profit rises 12 percent to Rs 184 cro...
- 04 November, 2025
AIIMS Delhi doctors told to use Hindi in prescript...
- 04 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!